Guided Therapeutics (GTHP) EPS (Basic) Growth (5y) (2015 - 2026)
Powered by 
Analysis
Guided Therapeutics (GTHP) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 19.31 Mn | 19.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.97% |
| Mar 31, 2026 | 15.69% |
| Dec 31, 2025 | -16.16% |
| Sep 30, 2025 | -16.24% |
| Jun 30, 2025 | 51.25% |
| Mar 31, 2025 | -15.05% |
| Dec 31, 2024 | -15.31% |
| Sep 30, 2024 | 19.75% |
| Jun 30, 2024 | 55.66% |
| Mar 31, 2024 | 34.91% |
| Dec 31, 2023 | -9.83% |
| Sep 30, 2023 | -43.39% |
| Jun 30, 2023 | -31.28% |
| Mar 31, 2023 | -29.88% |
| Dec 31, 2022 | 85.36% |
| Sep 30, 2022 | 84.62% |
| Jun 30, 2022 | 85.48% |
| Mar 31, 2022 | 81.21% |
| Dec 31, 2021 | 91.81% |
| Sep 30, 2021 | 70.57% |